Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii

Peptides

Volumn 31, Issue 10, 2010, Pages 1806-1810

  Conlon, J Michael ^a   Ahmed, Eman ^a   Pal, Tibor ^a   Sonnevend, Agnes ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Acinetobacter baumannii; Alyteserin 1c; Antibiotic resistance; Antimicrobial peptide

Indexed keywords

ALANINE; ALPHA AMINO ACID; ALYTESIN; GLUTAMIC ACID; GLYCYLLEUCYLLYSYLGLUTAMYLISOLEUCYLPHENYLALANYLLYSYLALANYLGLYCYLLEUCYLGLYCYLSERYLLEUCYLVALYLLYSYLGLYCYLISOLEUCYLALANYLALANYLHISTIDYLVALYLALANYLSERINAMIDE; LYSINE; PALMITIC ACID; UNCLASSIFIED DRUG; VALINE;

ACINETOBACTER BAUMANNII; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG POTENCY; ERYTHROCYTE; HEMOLYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SKIN SECRETION; TOAD;

ACINETOBACTER BAUMANNII; AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROCYTES; HEMOLYSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA;

ACINETOBACTER BAUMANNII; ALYTES OBSTETRICANS;

EID: 77956669561     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.06.032     Document Type: Article

References (44)

1. R. Bessalle, H. Haas, A. Goria, I. Shalit, and M. Fridkin Augmentation of the antibacterial activity of magainin by positive-charge chain extension Antimicrob Agents Chemother 36 1992 313 317
2. Y. Chen, M.T. Guarnieri, A.I. Vasil, M.L. Vasil, C.T. Mant, and R.S. Hodges Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides Antimicrob Agents Chemother 51 2007 1398 1406
3. Clinical Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M07-A8 2008 CLSI Wayne, PA
4. Clinical Laboratory Standards Institute Reference method for broth dilution antifungal susceptibility testing of yeast. Approved Standard M27-A3 2008 CLSI Wayne, PA
5. J.M. Conlon The therapeutic potential of antimicrobial peptides from frog skin Rev Med Micro 15 2004 17 25
6. J.M. Conlon, E. Ahmed, and E. Condamine Antimicrobial properties of brevinin-2-related peptide and its analogs: efficacy against multidrug-resistant Acinetobacter baumannii Chem Biol Drug Des 74 2009 488 493
7. J.M. Conlon, N. Al-Ghaferi, B. Abraham, and J. Leprince Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents Methods 42 2007 349 357
8. J.M. Conlon, A. Demandt, P.F. Nielsen, J. Leprince, H. Vaudry, and D.C. Woodhams The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae) Peptides 30 2009 1069 1073
9. J.M. Conlon, S. Galadari, H. Raza, and E. Condamine Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7 Chem Biol Drug Des 72 2008 58 64
10. K.F. Croom, and P.L. McCormack Liraglutide: a review of its use in type 2 diabetes mellitus Drugs 69 2009 1985 2004
11. S.F. Dallo, and T. Weitao Insights into acinetobacter war-wound infections, biofilms, and control Adv Skin Wound Care 23 2010 169 174
12. M. Dathe, T. Wieprecht, H. Nikolenko, L. Handel, W.L. Maloy, and D.L. MacDonald Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides FEBS Lett 403 1997 208 212
13. G. Diamond, N. Beckloff, A. Weinberg, and K.O. Kisich The roles of antimicrobial peptides in innate host defense Curr Pharm Des 15 2009 2377 2392
14. L. Dijkshoorn, A. Nemec, and H. Seifert An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii Nat Rev Microbiol 5 2007 939 951
15. A. Giacometti, O. Cirioni, M.S. Del Prete, F. Barchiesi, A.M. Paggi, and E. Petrelli Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii J Antimicrob Chemother 46 2000 807 810
16. H. Giamarellou, A. Antoniadou, and K. Kanellakopoulou Acinetobacter baumannii: a universal threat to public health? Int J Antimicrob Agents 32 2008 106 119
17. H. Giamarellou, and G. Poulakou Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs 69 2009 1879 1901
18. T.D. Gootz, and A. Marra Acinetobacter baumannii: an emerging multidrug-resistant threat Expert Rev Anti Infect Ther 6 2008 309 325
19. N.C. Gordon, and D.W. Wareham Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance Int J Antimicrob Agents 35 2010 219 226
20. D.M. Guerrero, F. Perez, N.G. Conger, J.S. Solomkin, M.D. Adams, and P.N. Rather Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease Surg Infect (Larchmt) 11 2010 49 57
21. D.E. Karageorgopoulos, and M.E. Falagas Current control and treatment of multidrug-resistant Acinetobacter baumannii infections Lancet Infect Dis 8 2008 751 762
22. K.S. Ko, J.Y. Suh, K.T. Kwon, S.I. Jung, K.H. Park, and C.I. Kang High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea J Antimicrob Chemother 60 2007 1163 1167
23. J. Kyte, and R.F. Doolittle A simple method for displaying the hydropathic character of a protein J Mol Biol 157 1982 105 132
24. D.M. Livermore Has the era of untreatable infections arrived? J Antimicrob Chemother 64 Suppl. 1 2009 i29 36
25. L.L. Maragakis, and T.M. Perl Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options Clin Infect Dis 46 2008 1254 1263
26. S.R. Norrby, C.E. Nord, and R. Finch Lack of development of new antimicrobial drugs: a potential serious threat to public health Lancet Infect Dis 5 2005 115 119
27. T. Pál, A. Sonnevend, S. Galadari, and J.M. Conlon Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2 Regul Pept 129 2005 85 91
28. A.Y. Peleg, J. Adams, D.L. Paterson, and Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii Antimicrob Agents Chemother 51 2007 2065 2069
29. A.Y. Peleg, H. Seifert, and D.L. Paterson Acinetobacter baumannii: emergence of a successful pathogen Clin Microbiol Rev 21 2008 538 582
30. F. Perez, A.M. Hujer, K.M. Hujer, B.K. Decker, P.N. Rather, and R.A. Bonomo Global challenge of multidrug-resistant Acinetobacter baumannii Antimicrob Agents Chemother 51 2007 3471 3484
31. G.G. Perron, M. Zasloff, and G. Bell Experimental evolution of resistance to an antimicrobial peptide Proc Biol Sci 273 2006 251 256
32. J.P. Powers, and R.E. Hancock The relationship between peptide structure and antibacterial activity Peptides 24 2003 1681 1691
33. A.C. Rinaldi Antimicrobial peptides from amphibian skin: an expanding scenario Curr Opin Chem Biol 6 2002 799 804
34. J.M. Saugar, M.J. Rodríguez-Hernández, B.G. de la Torre, M.E. Pachón-Ibañez, M. Fernández-Reyes, and D. Andreu Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action Antimicrob Agents Chemother 50 2006 p. 1251-6
35. M. Schiffer, and A.B. Edmundson Use of helical wheels to represent the structures of proteins and to identify segments with helical potential Biophys J 7 1967 121 135
36. P.J. Sebeny, M.S. Riddle, and K. Petersen Acinetobacter baumannii skin and soft-tissue infection associated with war trauma Clin Infect Dis 47 2008 444 449
37. T. Tachi, R.F. Epand, R.M. Epand, and K. Matsuzaki Position dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity Biochemistry 41 2002 10723 10731
38. K.J. Towner Acinetobacter: an old friend, but a new enemy J Hosp Infect 73 2009 355 363
39. J.F. Turton, S.N. Gabriel, C. Valderrey, M.E. Kaufmann, and T.L. Pitt Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii Clin Microbiol Infect 13 2007 807 815
40. J.F. Turton, N. Woodford, J. Glover, S. Yarde, M.E. Kaufmann, and T.L. Pitt Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species J Clin Microbiol 44 2006 2974 2976
41. J. Vila, and J. Pachón Therapeutic options for Acinetobacter baumannii infections Expert Opin Pharmacother 9 2008 587 599
42. T. Wieprecht, M. Dathe, E. Krause, M. Beyermann, W.L. Maloy, and D.L. MacDonald Modulation of membrane activity of amphipathic, antibacterial peptides by slight modifications of the hydrophobic moment FEBS Lett 417 1997 135 140
43. M.R. Yeaman, and N.Y. Yount Mechanisms of antimicrobial peptide action and resistance Pharmacol Rev 55 2003 27 55
44. M. Zasloff Antimicrobial peptides in health and disease N Engl J Med 347 2002 1199 1200